In a previous study, when FATP2 and FATP5 were specifically knocked down in the liver, the absorption of long-chain fatty liver was reduced, the formation of TG and lipid droplets was suppressed, and hepatic steatosis and insulin resistance were improved [47]. This evidence concerns the gene SLC27A2 and fatty liver disease.